Sign in or register to access exclusive content on this site
REGISTER

Home | Neuromuscular | Duchenne muscular dystrophy (DMD) | Publications | Publication: Transition of patients with Duchenne muscular dystrophy from paediatric to adult care: An international Delphi consensus study

Publication: Transition of patients with Duchenne muscular dystrophy from paediatric to adult care: An international Delphi consensus study

This article, in the European Journal of Paediatric Neurology, summarizes the Delphi consensus study, which aims to establish best practices for the transition of young people with Duchenne muscular dystrophy (DMD) to adult care, and ensure continuity of treatment

  • Review the consensus statements provided by international experts, patient representatives, and policy advisors
  • Learn more about the key topics outlined in the consensus guidelines, including the transition process and planning for patients living with DMD, and post-transfer management
  • Understand how the consensus statements provide an outline for effective communication between healthcare professionals and young people with DMD, ensuring better support throughout the transition to adulthood

Castro D, Sejersen T, Bello L et al. Eur. J. Paediatr. Neurol;54:130–139

Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.

Thank you!

Already registered?

Registration
* indicates a required field
  • This Website is intended only for healthcare professionals (“Website“), is operated by PTC Therapeutics. (together with its affiliates “PTC”). In order to access the restricted content on this Website:

    *
    *
  • PTC will delete immediately the information provided if we cannot confirm you are a healthcare professional.
    Otherwise, in case of successful verification, PTC will retain the information provided for a period of two (2) years following your registration (i) only for the purposes of providing you access to this Website; and/or (ii) in case you signed up to receive PTC updates.

Providing your personal data and your consent is voluntary, and you have the right to withdraw your consent at any time, without giving any reasons. Please consult our Privacy Statement for more information on the processing of your personal data.
For any inquiry relating to the processing of your personal data or if you want to exercise your privacy related rights or withdraw your consent, you can contact PTC’s Privacy Office at: Dataprivacy@ptcbio.com.

You can unsubscribe from updates at any time when receiving an email from PTC.

MED-ALL-DMD-2500029 | June 2025

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This website may include scientific information about investigational and unlicensed products not approved for use within your country. Please refer to local regulatory guidance for country-specific information

© 2025 PTC Therapeutics. All rights reserved | MED-ALL-CORP-2200029 | June 2025

This content is protected.

To view it please enter your email address below:

Register here to access the content on the site

MED-ALL-CORP-2200029 | June 2025

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.